Tefron Ltd.
TFRFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $95 | $46 | $32 | $94 |
| - Cash | $6 | $3 | $4 | $4 |
| + Debt | $16 | $25 | $59 | $45 |
| Enterprise Value | $104 | $68 | $87 | $136 |
| Revenue | $294 | $243 | $222 | $261 |
| % Growth | 20.7% | 9.5% | -14.9% | – |
| Gross Profit | $66 | $55 | $49 | $54 |
| % Margin | 22.6% | 22.6% | 22.1% | 20.6% |
| EBITDA | $31 | $26 | $20 | $21 |
| % Margin | 10.6% | 10.6% | 8.9% | 8% |
| Net Income | $15 | $11 | $7 | $14 |
| % Margin | 5.1% | 4.5% | 3.3% | 5.5% |
| EPS Diluted | 1.13 | 0.86 | 0.55 | 1.15 |
| % Growth | 31.4% | 56.4% | -52.2% | – |
| Operating Cash Flow | $31 | $46 | -$4 | -$3 |
| Capital Expenditures | -$9 | -$7 | -$3 | -$4 |
| Free Cash Flow | $22 | $39 | -$7 | -$8 |